North America Single Cell Sequencing Market (2025-2030)
The North America Single Cell Sequencing Market was valued at $654.5 Million in 2025 and projected to reach to $1100.7 Million by 2030, representing a compound annual growth rate of 11.0%. North America's single cell sequencing market is poised for sustained growth through 2030, expanding from $654.5 million in 2025 to $1,100.7 million at an 11% CAGR.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Single Cell Sequencing Market Trends and Insights
- This 11.0% compound annual growth rate reflects North America's leadership in genomic research infrastructure, advanced healthcare systems, and substantial investment in precision medicine initiatives.
- North America benefits from a concentration of leading research institutions, biopharmaceutical companies, and diagnostic laboratories driving adoption of single cell sequencing technologies. The North America market is propelled by increasing demand for personalized medicine, cancer research applications, and immunology studies across the region.
- North America's regulatory environment and reimbursement frameworks continue to support commercialization of single cell sequencing platforms and services.
- Between 2025 and 2030, North America is expected to maintain its competitive advantage through continued innovation in sequencing chemistry, bioinformatics solutions, and integrated workflow platforms that address the region's evolving research and clinical needs..
Key Market Statistics
- CAGR (2025-2030) 11.0% CAGR
- Market Size, 2025 ~USD 654.5 Million
- Forecast, 2030 ~USD 1100.7 Million
- Geography North America
North America Single Cell Sequencing Market Overview
Market Leadership Position :
North America commands the largest share of the global single cell sequencing market, driven by advanced research infrastructure, leading academic institutions, and significant government funding for genomic research initiatives across the US and Canada.
Precision Medicine Investment :
Substantial investment in precision medicine and personalized healthcare across North America is accelerating single cell sequencing adoption, with major pharmaceutical companies and biotech firms establishing research centers focused on cellular-level analysis.
Technological Innovation Hub :
North America hosts key technology developers and sequencing platform manufacturers, fostering rapid innovation cycles and early adoption of next-generation single cell sequencing technologies in clinical and research settings.
Regulatory Support & Funding :
Favorable regulatory frameworks, NIH grants, and substantial venture capital funding in North America create an enabling environment for single cell sequencing market expansion and commercialization of novel applications.
North America Single Cell Sequencing Market Dynamics
- This growth trajectory reflects the region's commitment to advancing genomic research, increasing adoption in oncology, immunology, and neuroscience applications, and growing integration into clinical diagnostics.
- The US dominates the market with robust healthcare spending and research infrastructure, while Canada contributes significantly through collaborative research initiatives. Key drivers include rising demand for personalized medicine, expanding applications in drug discovery, and increasing accessibility of sequencing technologies.
- North American institutions continue to lead in publishing single cell research, attracting global talent and investment.
- Strategic partnerships between academic centers, biotech companies, and healthcare providers are expected to accelerate market penetration and drive innovation in single cell analysis methodologies through the forecast period..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- North America's single cell sequencing market is valued at $654.5 million in 2025 and will reach $1,100.7 million by 2030, representing an 11.0% CAGR.
- North America leads global adoption due to advanced research infrastructure, high healthcare spending, and concentration of biopharmaceutical innovation hubs.
- Cancer genomics, immunology, and personalized medicine applications are primary growth drivers in North America's single cell sequencing market.
- North America's favorable regulatory landscape and reimbursement policies accelerate commercialization and clinical integration of single cell sequencing technologies.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
North America Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
Target Audience
- Biotech & Sequencing Companies : Manufacturers and developers of single cell sequencing platforms need North America market intelligence to optimize product positioning, identify clinical adoption opportunities, and guide R&D investment in this leading genomic research region.
- Pharmaceutical & Drug Discovery Firms : Pharma companies leveraging single cell sequencing for drug discovery and development require detailed North American market data to assess technology adoption rates, identify research partnerships, and plan precision medicine initiatives.
- Healthcare Systems & Hospitals : North American healthcare providers and diagnostic laboratories need market insights to evaluate single cell sequencing integration into clinical workflows, assess competitive offerings, and plan capital investments in genomic infrastructure.
- Research Institutions & Universities : Academic centers and research organizations require market data to benchmark their genomic capabilities, identify funding opportunities, and understand technology trends shaping the North American research landscape.
- Investors & Private Equity : Investment firms targeting the North American genomics sector need comprehensive market analysis to identify high-growth opportunities, evaluate portfolio companies, and assess market consolidation trends in single cell sequencing.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 1008.1 Million |
| Canada | USD 139.5 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($654.5M in 2025) with country-level breakdowns for the US and Canada, enabling accurate budget allocation and market entry strategies specific to this high-value region.
- Competitive Landscape Analysis : Understand the competitive dynamics unique to North America, including key players, market consolidation trends, and technology differentiation strategies that drive competitive advantage in this mature, innovation-focused market.
- Growth Driver Identification : Identify North America-specific growth catalysts including precision medicine adoption, clinical integration pathways, regulatory developments, and funding trends that differ from global market dynamics.
- Investment & Partnership Opportunities : Discover strategic investment targets, acquisition candidates, and partnership opportunities within North America's robust biotech ecosystem, supported by detailed market segmentation and player positioning.
- Regulatory & Reimbursement Insights : Access North America-specific regulatory pathways, reimbursement models, and healthcare system dynamics that directly impact commercialization strategies and market penetration timelines for single cell sequencing solutions.
Frequently asked questions
What is the current market size of single cell sequencing in North America?
North America's single cell sequencing market is valued at $654.5 million in 2025 and is projected to grow to $1,100.7 million by 2030.
What is the expected growth rate for North America's single cell sequencing market?
North America's single cell sequencing market is expected to grow at a compound annual growth rate (CAGR) of 11.0% from 2025 to 2030.
Which applications drive the North America single cell sequencing market?
Key applications driving North America's market include cancer genomics research, immunology studies, stem cell biology, and personalized medicine development.
Why is North America a leading market for single cell sequencing?
North America leads due to its advanced research infrastructure, high healthcare expenditure, presence of major biopharmaceutical companies, and supportive regulatory frameworks.
What factors will influence North America's single cell sequencing market through 2030?
Key factors include increasing R&D investments, growing adoption in clinical diagnostics, technological advancements in sequencing platforms, and expanding applications in precision oncology.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- China Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
